scispace - formally typeset
Search or ask a question
JournalISSN: 2090-2913

Journal of skin cancer 

Hindawi Publishing Corporation
About: Journal of skin cancer is an academic journal published by Hindawi Publishing Corporation. The journal publishes majorly in the area(s): Skin cancer & Basal cell carcinoma. It has an ISSN identifier of 2090-2913. It is also open access. Over the lifetime, 197 publications have been published receiving 4007 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The authors review specific histopathological features and associated clinical outcomes of the primary subdivisions of squamous cell carcinoma, a wide diversity of SCC subtypes that are associated with markedly more aggressive behaviors.
Abstract: Nonmelanoma skin cancer (NMSC) is the most common form of cancer in the Caucasian population, with squamous cell carcinoma (SCC) accounting for the majority of NMSC-related metastases and death While most SCC lesions are indolent tumors with low malignant potential, a wide diversity of SCC subtypes exist, several of which are associated with markedly more aggressive behaviors Distinguishing these high-risk variants from their counterparts is possible through microscopic analysis, since each subtype possesses unique histopathological features Early identification of high-risk lesions can allow for more rapid therapeutic intervention, reducing the likelihood of metastasis and death The authors review specific histopathological features and associated clinical outcomes of the primary subdivisions of SCC

139 citations

Journal ArticleDOI
TL;DR: It is not very likely that MCC develops from differentiated MCs, but skin stem cells, probably from the epidermal lineage, are more likely to be cells of origin in MCC.
Abstract: Merkel cell carcinoma (MCC), a highly aggressive skin tumour with increasing incidence, is associated with the newly discovered Merkel cell polyomavirus (MCPyV). Studies on MCC and MCPyV as well as other risk factors have significantly increased our knowledge of MCC pathogenesis, but the cells of origin, which could be important targets in future therapies, are still unknown. Merkel cells (MCs), the neuroendocrine cells of the skin, were believed to be at the origin of MCC due to their phenotypic similarities. However, for several reasons, for example, heterogeneous differentiation of MCCs and postmitotic character of MCs, it is not very likely that MCC develops from differentiated MCs. Skin stem cells, probably from the epidermal lineage, are more likely to be cells of origin in MCC. Future studies will have to address these questions more directly in order to identify the physiological cells which are transformed to MCC cells.

115 citations

Journal ArticleDOI
TL;DR: The data suggests that the incidence of basal cell carcinomas is equal between males and females and the mutation type cannot be used to predict disease burden.
Abstract: Gorlin syndrome (Naevoid Basal Cell Carcinoma Syndrome) is a rare autosomal dominant syndrome caused by mutations in the PTCH gene with a birth incidence of approximately 1 in 19,000. Patients develop multiple basal cell carcinomas of the skin frequently in early life and also have a predisposition to additional malignancies such as medulloblastoma. Gorlin Syndrome patients also have developmental defects such as bifid ribs and other complications such as jaw keratocysts. We studied the incidence and frequency of basal cell carcinomas in 202 Gorlin syndrome patients from 62 families and compared this to their gender and mutation type. Our data suggests that the incidence of basal cell carcinomas is equal between males and females and the mutation type cannot be used to predict disease burden.

109 citations

Journal ArticleDOI
TL;DR: The diagnosis, pathology, clinical course, and treatment options for cutaneous squamous cell carcinoma of the head and neck are examined.
Abstract: Cutaneous squamous cell carcinoma of the head and neck is an epidemic that reaches all parts of the world. Making the diagnosis relies on the acumen of the clinician and pathologist. Various pathologic subtypes exist and differ in histology and prognosis. High-risk tumors need aggressive treatment and vigilant surveillance to monitor for recurrence. Large tumors, deep tissue invasion, perineural involvement, recurrence, location in high-risk areas, and immunosuppression are implicated in worsening prognosis. Surgery is the mainstay of treatment with adjuvant radiation therapy as needed for aggressive tumors; however, other modalities are potentially useful for low-risk lesions. The use of Mohs surgery has become increasingly useful and has shown high success rates. Involvement of parotid and neck lymph nodes significantly affects outcomes and the physician should be comfortable with management of this complex disease. This paper examines the diagnosis, pathology, clinical course, and treatment options for cutaneous squamous cell carcinoma of the head and neck.

100 citations

Journal ArticleDOI
TL;DR: It is suggested that individual AP1 transcription factors have different functions in the epidermis and in cancer development and that alteringAP1 transcription factor function in the basal versus suprabasal layers differentially influences theEpidermal differentiation response and disease and cancer development.
Abstract: AP1 (jun/fos) transcription factors (c-jun, junB, junD, c-fos, FosB, Fra-1, and Fra-2) are key regulators of epidermal keratinocyte survival and differentiation and important drivers of cancer development. Understanding the role of these factors in epidermis is complicated by the fact that each protein is expressed, at different levels, in multiple cells layers in differentiating epidermis, and because AP1 transcription factors regulate competing processes (i.e., proliferation, apoptosis, and differentiation). Various in vivo genetic approaches have been used to study these proteins including targeted and conditional knockdown, overexpression, and expression of dominant-negative inactivating AP1 transcription factors in epidermis. Taken together, these studies suggest that individual AP1 transcription factors have different functions in the epidermis and in cancer development and that altering AP1 transcription factor function in the basal versus suprabasal layers differentially influences the epidermal differentiation response and disease and cancer development.

98 citations

Performance
Metrics
No. of papers from the Journal in previous years
YearPapers
20232
202212
20218
20208
20197
20185